A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder
Public ClinicalTrials.gov record NCT04919512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label, Multi-Center, Randomized Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Scheduled for Radical Cystectomy and Are Ineligible for or Refusing Platinum-Based Neoadjuvant Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the anti-tumor effects of TAR-200 in combination with intravenous (IV) cetrelimab and IV cetrelimab alone.
Study identification
- NCT ID
- NCT04919512
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 163 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 7, 2022 (Actual)
- Primary completion
- Feb 4, 2025 (Actual)
- Completion
- Mar 31, 2026 (Actual)
- Last update posted
- Jun 23, 2026
2022 – 2026
United States locations
- U.S. sites
- 41
- U.S. states
- 25
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Urological Associates of Southern Arizona, P.C. | Tucson | Arizona | 85741 | — |
| UAMS Winthrop P. Rockefeller Cancer Institute | Little Rock | Arkansas | 72205 | — |
| Arkansas Urology | Little Rock | Arkansas | 72211 | — |
| City of Hope | Duarte | California | 91010 | — |
| Genesis Research | San Diego | California | 92123 | — |
| Colorodo Urology- St. Anthony Hospital | Golden | Colorado | 80401 | — |
| University of Florida Health Jacksonville | Jacksonville | Florida | 32209 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| Baptist Hospital of Miami | Miami | Florida | 33176 | — |
| Winship Cancer Institute Emory University | Atlanta | Georgia | 30322 | — |
| DuPage Medical Group | Lisle | Illinois | 60532 | — |
| Urology of Indiana | Indianapolis | Indiana | 46260 | — |
| First Urology | Jeffersonville | Indiana | 47130 | — |
| University of Louisville - James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| University Of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Penn Medicine - PerelmanCenter for Advanced Medicine | Baltimore | Maryland | 21218 | — |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | — |
| Michigan Institute of Urology, PC | Troy | Michigan | 48084 | — |
| University Of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic 1 | Rochester | Minnesota | 55905 | — |
| Ellis Fischel Cancer Center | Columbia | Missouri | 65201 | — |
| Washington University School Of Medicine - Center For Advanced Medicine (CAM) | St Louis | Missouri | 63110-1010 | — |
| David C. Pratt Cancer Center | St Louis | Missouri | 63141 | — |
| Robert Wood Johnson University Hospital | New Brunswick | New Jersey | 08901 | — |
| Mount Sinai Queens Infusion Center | Astoria | New York | 11102 | — |
| New York University Langone Medical Center | New York | New York | 10017 | — |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | — |
| SUNY Upstate Medical University | Syracuse | New York | 13202 | — |
| Associated Medical Professionals | Syracuse | New York | 13210 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Wake Forest University Baptist Medical Center (WFUBMC) - Comprehensive Cancer Center | Winston-Salem | North Carolina | 27103 | — |
| The Ohio State University | Columbus | Ohio | 43210 | — |
| MidLantic Urology | Bala-Cynwyd | Pennsylvania | 19004 | — |
| University Of Pittsburgh Medical Center UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology Associates | Nashville | Tennessee | 37209 | — |
| Houston Metro Urology | Houston | Texas | 77027 | — |
| Urology San Antonio Research | San Antonio | Texas | 78229 | — |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | — |
| University of Washington School of Medicine | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 68 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04919512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04919512 live on ClinicalTrials.gov.